Simplify Health Care ETF
$38.26−0.84 (−2.15%)
- Expense ratio
- 0.51%
- Fund size
- $361M
- 1Y return
- +25.1%
- Yield · Last 12 months
- 0.64%
- Holdings
- 58
- Volume · 30D
- 0.1M sh
- NAV per share
- $38.92
- 52W range
The ETF.net PINK Grade
Score 50 of 100 sits in the C band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.CScore 46Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.Not scoredRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.BScore 62Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.CScore 51Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.CScore 49Category rankDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.CScore 53Category rank
Our read on PINK
CMost big health care ETFs just buy the index and sit still. PINK is a stock picker: roughly 60 U.S. names chosen bottom-up, multi-cap, growth-leaning, with room to back companies developing new medicines or cutting system costs.
PINK seeks long-term capital appreciation through U.S. health care companies, using a multi-cap, fundamental bottom-up approach. It generally follows a growth strategy and may emphasize companies developing medicines or improving health-care-system cost or quality.
Why people hold it
- Active by design: about 60 U.S. health care names picked bottom-up, not several hundred sorted by market cap. Concentration cuts both ways, but each pick actually matters here.
- Measured against an all-cap health care benchmark, so small and mid caps are in play, not just the megacap pharma that dominates S&P 500 based sector funds like XLV and RSPH.
- Charges 0.51%, right at the category median, which is unusual pricing for a hand-picked portfolio rather than an index feed.
- Sits in the upper half of the broad health care sector group on our review, and pays out quarterly.
Worth knowing
- The category's index heavyweights (VHT, FHLC, XLV) charge under a tenth of a percent. PINK's fee is roughly six times that, and it buys the manager's judgment.
- No index to hug. Holdings come from a manager's calls, so the fund can sit far from the health care benchmark in either direction.
- One sector, one country, about 60 holdings, growth lean. Trial results and health policy headlines land with full force here.
PINK Holdings
- Stocks
- 58
- 57%
- LLY
Sectors
- Health Care90.6%
- Industrials5.5%
- Consumer Discr.4.0%
Geography
- United States96.23%
- Ireland3.76%
- France0.01%
PINK Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | PINK |
|---|---|
| Year to date | +7.2% |
| 1 month | −2.7% |
| 3 months | +4.7% |
| 1 year | +25.1% |
| 3 years | +16.1% |
| 5 years | — |
| 10 years | — |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | PINK |
|---|---|---|
| 2026 YTD | +7.2% | |
| 2025 | +24.4% | |
| 2024 | +8.8% | |
| 2023 | +3.8% | |
| 2022 | −4.4% | |
| 2021 | +12.2% |
PINK in the news
ETF.net Research hasn’t filed on PINK yet — coverage lands here as it’s written.
PINK Dividends
- 0.64%
- $0.25
- $0.05 per share
- Quarterly
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Jun 25, 2026 | Jun 30, 2026 | $0.05 |
| Mar 26, 2026 | Mar 31, 2026 | $0.05 |
| Dec 23, 2025 | Dec 31, 2025 | $0.10 |
| Sep 25, 2025 | Sep 30, 2025 | $0.05 |
| Jun 25, 2025 | Jun 30, 2025 | $0.05 |
| Mar 26, 2025 | Mar 31, 2025 | $0.05 |
| Dec 23, 2024 | Dec 31, 2024 | $0.01 |
| Sep 25, 2024 | Sep 30, 2024 | $0.02 |
| Jun 25, 2024 | Jun 28, 2024 | $0.03 |
| Mar 25, 2024 | Mar 28, 2024 | $0.03 |
| Dec 26, 2023 | Dec 29, 2023 | $0.08 |
| Sep 27, 2023 | Sep 29, 2023 | $0.03 |
PINK Risk
- 16.6%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.66
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −18.8%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 0.73
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
PINK Cost
- The middle half of Health Care (Broad) funds
- Median 0.50%
13 of the 25 Health Care (Broad) funds charge less.